Skip to main content

Home/ Dr. Goodyear/ Group items tagged IGT

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Nathan Goodyear

Glucagon-like peptide 1 improves the ability of th... [Diabetes. 1998] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...9703326

glucagon-like peptid-1 insulin glucose control diabetes resistance

shared by Nathan Goodyear on 06 Apr 11 - No Cached
  • We concluded that low dosage GLP-1 improves the ability of the beta-cell to secrete insulin in both IGT and NIDDM subjects, but that the ability to sense and respond to subtle changes in plasma glucose is improved in IGT subjects, with only a variable response in NIDDM subjects. Beta-cell dysfunction was improved by GLP-1 infusion, suggesting that early GLP-1 therapy may preserve beta-cell function in subjects with IGT or mild NIDDM.
  • Nathan Goodyear on 06 Apr 11
     
    glucagon-like peptide-1 improves insulin/glucose regulation
Nathan Goodyear

Intensive Lifestyle Intervention or Metformin on Inflammation and Coagulation in Partic... - 0 views

diabetes.diabetesjournals.org/...1566

CRP metformin type II diabetes DM IGT insulin resistance inflammation inflammatory markers lifestyle intervention glucose tolerance

shared by Nathan Goodyear on 20 Dec 11 - No Cached
  • Nathan Goodyear on 20 Dec 11
     
    Large study of over 3,000 adults shows lifestyle changes are more effective, than metformin, in reducing development of type II diabetes.  CRP, inflammatory marker, reduced at 1 year more in lifestyle (29%) versus metformin (14%).     And don't forget all the nutritional deficiencies that metformin creates.
1 - 2 of 2
Showing 20▼ items per page